Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
Clinical trial NCT02842112 · COMPLETED
Trial details
- NCT number
- NCT02842112
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.